ALLO vs MOS · rev $22.0K vs P/E 161, rev $11.12B
Allogene Therapeutics Inc (ALLO) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
ALLO currently screens at market cap $258.1M. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the ALLO and MOS stock pages for the full models.
Not investment advice.